Primary Category:
Radiation Oncology, Treatment Protocols
Disease Category:
Other
Status:
Temporarily Closed
Phase II Randomized Trial of Atezolizumab Versus Atezolizumab and Radiation Therapy for Platinum Ineligible/Refractory Metastatic Urothelial Cancer (ART)
NCT#04936230
A032002 is temporarily closed to accrual, effective February 9, 2023.
